ampelopsin has been researched along with Fatty Liver, Nonalcoholic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 9 (90.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyasaka, K; Shimizu, N; Shimoda, H; Takeda, S; Wu, J; Yamada, W | 1 |
| Cao, H; Chen, L; Lin, S; Lyu, Q; Teng, H | 1 |
| Gong, H; Li, M; Xu, H; Zhang, D | 1 |
| Chen, Y; Liu, J; Luo, P; Miao, X; Wang, J | 1 |
| Li, X; Liu, L; Sun, S | 1 |
| Huang, S; Jin, R; Li, X; Tan, L; Tong, H; Zhang, X | 1 |
| Hua, YQ; Wang, W; Xu, XL; Zeng, Y; Zhang, H | 1 |
| Chen, K; He, X; Hou, DX; Sakao, K; Xie, K | 1 |
| Bi, Y; Chen, J; Fu, J; Liu, B; Wang, X; Xia, T; Zhu, R | 1 |
| Chen, S; Gao, Y; Liu, P; Mi, M; Qin, Y; Ran, L; Shu, F; Wan, J; Wang, X; Zhang, Q; Zhang, Y; Zhao, X; Zhu, J | 1 |
3 review(s) available for ampelopsin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease.
Topics: Flavonols; Humans; Lipid Metabolism; Liver; Non-alcoholic Fatty Liver Disease | 2022 |
Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases.
Topics: Animals; Atherosclerosis; Diabetes Mellitus; Flavonols; Gene Expression Regulation; Humans; Hypoglycemic Agents; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Osteoporosis; Signal Transduction | 2020 |
Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease.
Topics: Carcinoma, Hepatocellular; Flavonols; Humans; Liver Diseases; Liver Diseases, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Liver Regeneration; Non-alcoholic Fatty Liver Disease; Protective Agents | 2021 |
1 trial(s) available for ampelopsin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial.
Topics: Adult; Ampelopsis; Biomarkers; Double-Blind Method; Female; Flavonols; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Plants, Medicinal | 2015 |
6 other study(ies) available for ampelopsin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models.
Topics: 3T3-L1 Cells; Adiposity; Animals; Anti-Obesity Agents; Antioxidants; Diet, High-Fat; Fatty Liver, Alcoholic; Flavonoids; Lipid Metabolism; Lipogenesis; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea | 2022 |
A designed self-microemulsion delivery system for dihydromyricetin and its dietary intervention effect on high-fat-diet fed mice.
Topics: Animals; Diet, High-Fat; Flavonols; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2022 |
Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora.
Topics: Animals; Bile Acids and Salts; Choline Deficiency; Gastrointestinal Microbiome; Ileum; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Triglycerides | 2023 |
A network pharmacology-based approach to explore the effect of dihydromyricetin on non-alcoholic fatty liver rats via regulating PPARG and CASP3.
Topics: Animals; Caspase 3; Lipid Metabolism; Liver; Network Pharmacology; Non-alcoholic Fatty Liver Disease; Palmitic Acid; PPAR gamma; Rats; Triglycerides | 2023 |
Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin.
Topics: Age Factors; Animals; Cell Line, Transformed; Diet, High-Fat; Flavonols; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Receptors, LDL; Sirtuin 1 | 2020 |
Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD.
Topics: AMP-Activated Protein Kinases; Ampelopsis; Animals; Antioxidants; Carnitine O-Palmitoyltransferase; Cytochrome P-450 CYP4A; Diet, High-Fat; Diet, Western; Drugs, Chinese Herbal; Flavonols; Gastrointestinal Microbiome; Hep G2 Cells; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lipid Metabolism; Liver; Membrane Proteins; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phytotherapy; PPAR alpha; Teas, Herbal | 2020 |